Paloma Partners’s DexCom DXCM Stock Holding History

Paloma Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,200	Closed	-$411K	–	767
2023 Q2	$411K	Buy	+3,200	New	+$387K	0.01%	506
2022 Q4	–	Sell	-7,000	Closed	-$564K	–	975
2022 Q3	$564K	Buy	+7,000	New	+$593K	0.03%	449
2019 Q4	–	Sell	-8,000	Closed	-$298K	–	2236
2019 Q3	$298K	Buy	+8,000	New	+$311K	0.01%	1531
2019 Q2	–	Sell	-13,600	Closed	-$405K	–	1831
2019 Q1	$405K	Buy	+13,600	New	+$478K	0.01%	1175

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Paloma Partners's DXCM Position: Q2 2025 in Review

Paloma Partners sold out of DexCom (DXCM) in Q2 2025, closing a stake of 3,164 shares — an estimated $216K sold.

Paloma Partners first reported a position in DXCM in Q1 2015 and held it in 24 quarters. The position peaked at $15.1M in Q2 2020. 940 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

Paloma Partners reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
Paloma Partners sold 3,164 DexCom shares in Q2 2025, an estimated $216K.
Paloma Partners first reported a position in DexCom in Q1 2015 and held it in 24 quarters.
Paloma Partners's DexCom position peaked at $15.1M in Q2 2020.
940 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.